Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

DXLGBullishM&Anews

High materiality7/10

DXL Board Evaluates Revised $0.84 Cash Tender Offer from Zodiac

Jun 23, 2026, 5:01 PM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

A higher, revised cash offer and ongoing board review create a potential price floor near $0.84 if a deal progresses; however, certainty remains pending Schedule 14D-9 disclosures and any competing bids.

AI summary

What happened, with direct paths to the underlying reporting

DXL's board is evaluating Zodiac's revised $0.84 cash offer for all outstanding DXLG shares. It previously rejected a $0.82 bid, citing opportunism and timing; a Schedule 14D-9 amendment will be filed and reviewed with advisers, keeping stockholders in the loop as a potential take-private unfolds.

Zodiac proposes revised offer at $0.84 cash per DXLG share.
DXL previously rejected $0.82; board will review with advisors.
Board to file Schedule 14D-9 amendment; no action advised yet.
DXL advisors include Guggenheim Securities, Greenberg Traurig, Joele Frank.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

DXL Board Evaluates Revised $0.84 Cash Tender Offer from Zodiac

DXL backs away from FullBeauty merger, signals strategic reevaluation

Destination XL Group And FullBeauty To Create $1.2 Billion Merger